VBI Vaccines
VBIV
#10526
Rank
C$2.56 M
Marketcap
C$0.08943
Share price
0.00%
Change (1 day)
-89.70%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): C-$13.57

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is C-$13.89. In 2022 the company made an earnings per share (EPS) of C-$18.08 a decrease over its 2021 EPS that were of C-$11.09.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)C-$13.57
2022C-$18.0862.96%
2021C-$11.0928.57%
2020C-$8.63-54.35%
2019C-$18.90-52.58%
2018C-$39.8510.23%
2017C-$36.1614.29%
2016C-$31.64-62.8%
2015C-$85.0590.68%
2014C-$44.60-7.95%
2013C-$48.46-57.97%
2012C-$115.30-78%
2011C-$524.193151.47%
2010C-$16.1223.87%
2009C-$13.02-18.48%
2008C-$15.9712.08%
2007C-$14.25-49.47%
2006C-$28.19
2005N/A-100%
2004C-$12.5311.94%
2003C-$11.20-81.89%
2002C-$61.83196.44%
2001C-$20.8684.33%
2000C-$11.31-65.37%
1999C-$32.67-29.45%
1998C-$46.3129.61%
1997C-$35.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
C-$1.30-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
C-$5.03-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
C-$5.93-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA